Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
WPD Pharmaceuticals Inc
WPDPF
Primary Symbol:
C.WBIO
Industrials
Technology
WPD Pharmaceuticals Inc. is a Canada-based clinical-stage pharmaceutical company, with a focus on glioblastoma cancer (GBM) and other brain tumor programs. The Company is a biotechnology research and development company with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules. It has four novel drug candidates with one in...
clinical development stage and three in pre-clinical development. It operates its business primarily through WPD Poland, a subsidiary of and the operating branch of the Company. Its portfolio includes WPD101, Berubicin, and WPD103. WPD101 is a family of biopharmaceuticals in preclinical stages of development for targeted treatment of brain tumors with a global license. Berubicin is an anthracycline proven to cross the blood-brain barrier and able to reach brain tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:WBIO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(16)
•••
etcetera
X
View Profile
View Bullboard History
Post by
etcetera
on Jul 06, 2020 7:51am
Updates on Annamycin and WP1066
VANCOUVER, British Columbia, July 06, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. On June 25, Moleculin announced its presentation at the American Association of Cancer Research (AACR) Annual
...more
(16)
•••
etcetera
X
View Profile
View Bullboard History
Post by
etcetera
on Jun 22, 2020 8:39am
WPD licensor confirms WP1122's anti-viral potential
Moleculin Biotech Inc., the company that sublicenses the WP1122 compound to WPD Pharmaceuticals Inc. for WPD's use in 29 countries mainly in Europe, announced on June 16, 2020, that a repeat of
...more
(16)
•••
etcetera
X
View Profile
View Bullboard History
Comment by
etcetera
on Jun 11, 2020 8:46am
RE:WPD Pharmaceuticals clarifies WP1122 disclosure
Well, the SARS-COV-2 seems to be a path to follow as there is another company that is working on it Recombinant SARS-CoV-2 Proteins Now Available For Research From ImmunoPrecise's
...more
(16)
•••
etcetera
X
View Profile
View Bullboard History
Post by
etcetera
on Jun 11, 2020 7:12am
WPD Pharmaceuticals clarifies WP1122 disclosure
The future looks quite promising for WPD1122 In an April 9, 2020, press release, WPD disclosed that independent research found 2-deoxy-D-glucose (2-DG) to reduce replication of SARS-CoV-2, the
...more
(16)
•••
etcetera
X
View Profile
View Bullboard History
Post by
etcetera
on May 28, 2020 8:22am
WPD Pharmaceuticals Licensor Granted Another Key Patent
VANCOUVER, British Columbia, May 28, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to announce
...more
(16)
•••
etcetera
X
View Profile
View Bullboard History
Comment by
etcetera
on May 05, 2020 4:16pm
RE:RE:IIROC Trading Halt - WBIO
It is " bizarre " that the SEC in the United States stop a canadian company operating in CANADA In the meantime, here is a comment from WBIO The Company has contacted the SEC regarding
...more
(1)
•••
suomynona
X
View Profile
View Bullboard History
Comment by
suomynona
on May 05, 2020 10:21am
RE:RE:News Release Wording Over The Top?
Texas cancer-focused biotech Moleculin said its shares had been placed in a temporary trading halt following notification from the SEC. The small company, which has a market cap of about $65 million,
...more
(3)
•••
existabo
X
View Profile
View Bullboard History
Comment by
existabo
on May 05, 2020 9:01am
RE:IIROC Trading Halt - WBIO
Well well, the SEC also halt trading... Now this is serious, any thought ???
(16)
•••
etcetera
X
View Profile
View Bullboard History
Post by
etcetera
on May 04, 2020 2:15pm
IIROC Trading Halt - WBIO
News provided by Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions May 04, 2020, 14:02 ET VANCOUVER, May 4, 2020 /CNW/
...more
(3)
•••
existabo
X
View Profile
View Bullboard History
Comment by
existabo
on May 04, 2020 1:46pm
RE:Leading Polish Medical Institutions for Berubicin Phase 2
So much pumping,press release day afterday , yet no volume to follow through...
(16)
•••
etcetera
X
View Profile
View Bullboard History
Post by
etcetera
on Apr 30, 2020 8:13am
Leading Polish Medical Institutions for Berubicin Phase 2
WPD Pharmaceuticals and CNS Pharmaceuticals Identify Leading Polish Medical Institutions for Berubicin Phase 2 Clinical Trial Trials to be funded by a US$6 million grant previously awarded to WPD
...more
(16)
•••
etcetera
X
View Profile
View Bullboard History
Post by
etcetera
on Apr 29, 2020 9:54am
No CARDIOTOXICITY
Mariusz Olejniczak, CEO of WPD commented, "As Annamycin continues to advance, and studies so far have demonstrated the absence of any cardiotoxicity, we believe the trial can and should move
...more
(16)
•••
etcetera
X
View Profile
View Bullboard History
Post by
etcetera
on Apr 29, 2020 9:50am
WPD receives approval for Annamycin dose escalation
2020-04-29 07:33 ET - News Release Mr. Mariusz Olejniczak reports WPD PHARMACEUTICAL'S ANNAMYCIN DRUG APPROVED FOR ACCELERATED EUROPEAN CLINICAL TRIAL Through its licence partner
...more
(16)
•••
hintonkid
X
View Profile
View Bullboard History
Post by
hintonkid
on Apr 23, 2020 1:34pm
Gilead's CORVID-19 drug candidate fails in first trial.
I was just watching BNN Bloomberg a short while ago. Gilead's much touted CORVID-19 drug candidate has failed in it's first trial. As a result of the news, which was allegidly
...more
(82)
•••
ROUGETRADER719
X
View Profile
View Bullboard History
Post by
ROUGETRADER719
on Apr 13, 2020 1:36pm
Do be fooled or shook out there in the right place
With bigger pharma interested in the meds this is a buyout or a big runner sooner than later imo theny ran it up then triggered stops , the high of today will be support in days and weeks to
...more
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income